血液管理系统市场 - 全球产业规模、份额、趋势、机会及按类型、最终用户、地区和竞争格局分類的预测（2021-2031年）

全球血液管理系统市场预计将从 2025 年的 163.2 亿美元成长到 2031 年的 252.9 亿美元，复合年增长率为 7.57%。

该领域涵盖旨在管理整个血液供应链的综合硬体和软体解决方案，从捐血招募、血液采集和处理到库存管理和输血安全。推动这一增长的关键因素包括慢性血液疾病治疗中对血液成分的需求不断增长，以及透过高效的库存管理减少废弃物的必要性。此外，需要紧急输血的创伤事件增多，也促使医疗机构实施这些自动化工作流程，以确保血液製品的快速且准确地输送。

然而，实施这些大规模数位化平台所需的大量资本投入严重阻碍了市场扩张，这往往会对小规模医疗机构的预算造成巨大压力。此外，管理岌岌可危的血液供应所带来的营运难题也进一步加剧了这项财务障碍。美国血液中心协会 (ABC) 2025 年的数据显示，25% 的受监测机构报告称其库存水平不足一天，这凸显了这些系统所提供的精准资源优化能力的迫切需求。

市场驱动因素

在全球范围内，慢性疾病和创伤导致的紧急情况日益增多，这成为推动市场发展的主要因素，也凸显了建立能够高效调动和分配有限血液资源的系统的重要性。随着医疗机构努力满足血液疾病患者治疗和紧急转运的需求，捐血量与临床需求之间的差距持续扩大。这种脱节在发展中地区尤为严重。世界卫生组织（世卫组织）2025年5月发布的《血液安全与供应状况》报告指出，有60个国家每千人捐血不足10份，凸显了提高每单位血液效用的技术的重要性。

同时，自动化血液管理解决方案的快速技术进步正透过提高营运效率来变革整个产业。医院和血站正积极采用整合平台，实现捐血合格和库存管理的自动化，从而减少人为错误并控製成本。这种数位化转型也清楚地体现在主要产业参与者的财务表现中。例如，Haemonetics 在 2025 年年度报告（2025 年 5 月）中指出，其医院业务收入成长了 23.7%，这主要得益于血液管理技术的应用。此外，CSL Limited 报告称，2025 年净利润达到 33 亿美元，这主要得益于全球对高效管理血浆疗法的持续需求。

市场挑战

实施整合血液管理系统需要大量的初期投资，这给市场成长带来了巨大障碍，尤其对于财务柔软性有限的小规模医疗机构而言更是如此。这些数位化平台不仅需要大量的软体和自动化硬体投入，还需要与现有医院资讯系统进行复杂的整合。对许多机构而言，这种财务负担构成了一大障碍，迫使它们儘管面临营运风险，但仍依赖人工操作、分散的传统方法。因此，管理者不得不优先考虑紧迫的临床人员成本，而非基础设施升级，这大大减缓了这些自动化库存监控解决方案的普及速度。

这种经济压力体现在医疗保健产业利润率的下降，直接减少了可用于技术引进的可用资金。根据美国医院协会 (AHA) 2025 年的数据，人事费用约占医院总营运支出的 56%，严重限制了系统性改善的预算。由于这种严峻的财务环境，儘管血液管理系统能够提高效率，但其初始成本门槛有效地将许多潜在买家拒之门外，最终减缓了全球成长动能。

市场趋势

将人工智慧和机器学习技术应用于预测性库存分析，从根本上改变了血库管理供不应求和产品过期之间微妙平衡的方式。这些系统以动态演算法取代了静态的历史平均值，这些演算法能够考虑季节性波动和创伤患者趋势，使血库能够以前所未有的精度优化存量基准。这项变革对于最大限度地减少短效血小板和红血球的浪费，同时确保紧急输血的可用性至关重要。这项技术的应用效果是可以量化的：根据美国血库协会 (AABB) 2024 年 8 月发表的题为《血库中的人工智慧和资料科学》的报导，一家医院血库实施的混合计算模型使存量基准降低了约 40%，并实现了 43% 的成本节约。

此外，采用物联网智慧冷冻技术和低温运输监控系统已成为确保血液製品在储存和运输过程中保持物理完整性的关键趋势。与传统冷冻系统不同，这些智慧型系统利用远端感测器即时检测温度偏差，防止敏感血浆和生物检体劣化。该技术还透过先进的压缩机控制优化电力消耗，有助于实现医疗基础设施的永续性目标。根据海尔生物医疗2024年1月发布的新闻稿显示，该公司新推出的物联网超低温冷冻库技术在确保血站样本活性的同时，实现了50%的节能效果。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球血液管理系统市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（捐血管理模组、输血服务模组、库存管理、捐血计画管理、筛检和检测、报告和分析、整合和互通性、其他）
  • 按最终使用者（血库、医院、门诊护理中心等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美血液管理系统市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲血液管理系统市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区血液管理系统市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲血液管理系统市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲血液管理系统市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球血液管理系统市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT SA
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, SA
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Blood Management System Market is projected to expand from USD 16.32 Billion in 2025 to USD 25.29 Billion by 2031, registering a CAGR of 7.57%. This sector encompasses comprehensive hardware and software solutions designed to oversee the entire blood supply chain, ranging from donor recruitment and collection processing to inventory management and transfusion safety. Key factors propelling this growth include the increasing demand for blood components to manage chronic hematological conditions and the imperative to minimize waste through efficient inventory control. Furthermore, the rising volume of trauma incidents necessitating emergency transfusions is driving healthcare facilities to implement these automated workflows to ensure the rapid and accurate availability of blood products.

However, market expansion is significantly hindered by the high capital expenditure required to deploy these extensive digital platforms, which often strains the budgets of smaller healthcare providers. This financial barrier is aggravated by the operational difficulties involved in managing unstable blood supplies. According to data from America's Blood Centers in 2025, 25 percent of monitored centers reported operating with critical inventory levels of one day or less, highlighting the urgent need for the precise resource optimization capabilities that these systems provide.

Market Driver

The escalating global prevalence of chronic illnesses and trauma emergencies acts as a major catalyst for the market, creating a pressing need for systems that can efficiently mobilize and distribute scarce blood resources. As healthcare providers struggle to meet the demands of treating hematological disorders and emergency casualties, the gap between donor collection and clinical demand continues to widen. This discrepancy is particularly severe in developing regions; the World Health Organization's May 2025 update on 'Blood safety and availability' noted that 60 nations collected fewer than 10 donations per 1,000 people, emphasizing the critical importance of technologies that maximize the utility of every collected unit.

Simultaneously, rapid technological advancements in automated blood management solutions are transforming the sector by improving operational efficiency. Hospitals and blood centers are aggressively adopting integrated platforms to automate donor qualification and inventory tracking, thereby mitigating human error and controlling costs. This shift towards digitalization is evident in the performance of major industry players. For instance, Haemonetics reported in its 'Fiscal 2025 Annual Report' (May 2025) a 23.7 percent revenue increase in its Hospital business, driven largely by the adoption of blood management technologies. Furthermore, CSL Limited reported a net profit of $3.3 billion in 2025, underpinned by the sustained global demand for efficiently managed plasma therapies.

Market Challenge

The substantial upfront capital required to deploy integrated blood management systems serves as a severe obstruction to market growth, particularly for smaller healthcare facilities with limited financial flexibility. These digital platforms necessitate significant expenditure not only for the software and automated hardware but also for the complex integration into existing hospital information systems. For many institutions, this financial burden is prohibitive, forcing them to rely on manual or fragmented legacy methods despite the operational risks. Consequently, the adoption rate of these automated inventory oversight solutions slows significantly, as administrators are compelled to prioritize immediate clinical staffing costs over infrastructure upgrades.

This economic pressure is further evidenced by tightening profit margins across the healthcare sector, which directly reduces the disposable capital available for technological acquisition. According to the American Hospital Association in 2025, labor costs accounted for approximately 56 percent of total hospital operating expenses, leaving a strictly limited budget for systemic improvements. This intense fiscal strain means that although blood management systems offer efficiency gains, the initial cost barrier effectively locks a large segment of potential buyers out of the market, thereby flattening the global growth trajectory.

Market Trends

The integration of AI and Machine Learning for predictive inventory analytics is fundamentally reshaping how blood centers manage the delicate balance between supply shortages and product expiration. By replacing static historical averages with dynamic algorithms that account for seasonal fluctuations and trauma trends, these systems allow facilities to optimize stock levels with unprecedented precision. This shift is critical for minimizing the discard rates of short-shelf-life platelets and red blood cells while ensuring availability for emergency transfusions. The impact of this technological adoption is quantifiable; according to an AABB article from August 2024 titled 'AI and Data Sciences in Blood Banking', a hybrid computation model deployed for hospital blood banking reduced inventory levels by almost 40 percent and led to a cost reduction of 43 percent.

Additionally, the deployment of IoT-enabled smart refrigeration and cold chain monitoring is emerging as a vital trend to guarantee the physical integrity of blood products during storage and transport. Unlike traditional refrigeration, these smart systems utilize continuous remote sensors to detect temperature excursions in real-time, preventing the spoilage of sensitive plasma and biological samples. This technology also addresses sustainability goals within healthcare infrastructure by optimizing power consumption through advanced compressor regulation. According to Haier Biomedical's January 2024 newsletter, the company's new IoT-enabled ultra-low temperature freezer technology demonstrated a 50 percent energy saving capability while ensuring precise sample viability for blood stations.

Key Market Players

• Cerner Corporation
• Haemonetics Corporation
• Telvent GIT S.A.
• Terumo Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Baxter International Inc.
• Stryker Corporation
• Becton, Dickinson and Company
• Biolife Solutions, Inc.

Report Scope

In this report, the Global Blood Management System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management System Market, By Type

• Donor Management Module
• Transfusion Service Module
• Inventory Management
• Donation Scheduling
• Screening & Testing
• Reporting & Analytics
• Integration & Interoperability
• Others

Blood Management System Market, By End User

• Blood Banks
• Hospitals
• Ambulatory Care Centers
• Others

Blood Management System Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Management System Market.

Available Customizations:

Global Blood Management System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Management System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Donor Management Module, Transfusion Service Module, Inventory Management, Donation Scheduling, Screening & Testing, Reporting & Analytics, Integration & Interoperability, Others)
  • 5.2.2. By End User (Blood Banks, Hospitals, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Blood Management System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Blood Management System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Blood Management System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Blood Management System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Management System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. France Blood Management System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Blood Management System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Blood Management System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Blood Management System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia Pacific Blood Management System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Management System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Blood Management System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Blood Management System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Blood Management System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Blood Management System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Middle East & Africa Blood Management System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Management System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Blood Management System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Blood Management System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. South America Blood Management System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Management System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Blood Management System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Blood Management System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Management System Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Cerner Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Haemonetics Corporation
• 15.3. Telvent GIT S.A.
• 15.4. Terumo Corporation
• 15.5. Fresenius SE & Co. KGaA
• 15.6. Grifols, S.A.
• 15.7. Baxter International Inc.
• 15.8. Stryker Corporation
• 15.9. Becton, Dickinson and Company
• 15.10. Biolife Solutions, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer